Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes
about
High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients.The prognostic value of 14-3-3 isoforms in vulvar squamous cell carcinoma cases: 14-3-3β and ε are independent prognostic factors for these tumors.Primary tumor vascularity, HIF-1α and VEGF expression in vulvar squamous cell carcinomas: their relationships with clinicopathological characteristics and prognostic impact.Expression profiling of vulvar carcinoma: clues for deranged extracellular matrix remodeling and effects on multiple signaling pathways combined with discrete patient subsetsExpression of CDK1(Tyr15), pCDK1(Thr161), Cyclin B1 (total) and pCyclin B1(Ser126) in vulvar squamous cell carcinoma and their relations with clinicopatological features and prognosisLigand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displaying in vitro efficacy against melanoma cellsMicroRNA-141 is downregulated in human renal cell carcinoma and regulates cell survival by targeting CDC25B.Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategiesOxidative stress-induced DNA damage of mouse zygotes triggers G2/M checkpoint and phosphorylates Cdc25 and Cdc2.The Expression and Clinical Outcome of pCHK2-Thr68 and pCDC25C-Ser216 in Breast Cancer.Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.Potential Clinical Uses of CDK Inhibitors: Lessons from Synthetic Lethality Screens.miR-142-3p inhibits cancer cell proliferation by targeting CDC25C.Part II-mechanism of adaptation: A549 cells adapt to high concentration of nitric oxide through bypass of cell cycle checkpoints.Abortive cell cycle events in the brains of scrapie-infected hamsters with remarkable decreases of PLK3/Cdc25C and increases of PLK1/cyclin B1.Genotoxic stress modulates CDC25C phosphatase alternative splicing in human breast cancer cell lines.Covalent inhibition of protein tyrosine phosphatases.Differential expression of CDC25 phosphatases splice variants in human breast cancer cells.CDC25A-inhibitory RE derivatives bind to pocket adjacent to the catalytic site.High expression of Cdc25B and low expression of 14-3-3σ is associated with the development and poor prognosis in urothelial carcinoma of bladder.
P2860
Q31119438-75CD4C06-0A37-46AF-BEE0-93078B0632B0Q34026329-6EEDBAAA-314C-4D35-9587-42CE09BE96ABQ35027303-2526B42B-1299-4200-BEDC-F14DABFB87D4Q35182595-01BC774B-71E6-4050-A65A-6F0B6621D0FAQ35304430-39EB3061-B103-4DC6-BC55-717E1A9F8EA7Q35810554-C70129DA-159A-490A-8997-A7415EEFB172Q36768660-65FFC8F4-7E26-4943-8D78-1921085EC34FQ36889310-078461C1-2E7D-4AA1-BBD5-EC8590D7ECBFQ37004597-F9C0BD8B-3766-4950-80E1-4C8AEAAC9D44Q37465400-5DE5B97C-5D8B-4939-A3FF-F39F9D23DAF3Q38310745-99BB5877-DFA8-4106-927C-6E58D592DAB9Q38538589-0A471407-796D-4F69-9B19-2E2644EFD515Q38799902-D01357F8-155A-47FB-8F35-8F149727AAB2Q39062275-DA172AE3-4C55-4800-8402-7B8AA3B01BDDQ39159112-747F0B6E-B3CA-4F33-BF9D-E3FF8D69CFFCQ39301082-52F1712B-BF7C-48B5-8092-C4C2B7C7D6D7Q39324501-620515C9-AE76-43E5-AADA-849F00AEEB47Q39524071-1EE379BA-AE25-4835-86C1-E781E67E0C79Q46154159-C6EE7673-5342-495C-AF2D-99B0A3E6D278Q53083046-9EADD163-CC45-4867-A224-90001A4B7C86
P2860
Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Overexpression of CDC25B, CDC2 ...... d aggressive cancer phenotypes
@ast
Overexpression of CDC25B, CDC2 ...... d aggressive cancer phenotypes
@en
Overexpression of CDC25B, CDC2 ...... aggressive cancer phenotypes.
@nl
type
label
Overexpression of CDC25B, CDC2 ...... d aggressive cancer phenotypes
@ast
Overexpression of CDC25B, CDC2 ...... d aggressive cancer phenotypes
@en
Overexpression of CDC25B, CDC2 ...... aggressive cancer phenotypes.
@nl
prefLabel
Overexpression of CDC25B, CDC2 ...... d aggressive cancer phenotypes
@ast
Overexpression of CDC25B, CDC2 ...... d aggressive cancer phenotypes
@en
Overexpression of CDC25B, CDC2 ...... aggressive cancer phenotypes.
@nl
P2093
P2860
P356
P1433
P1476
Overexpression of CDC25B, CDC2 ...... d aggressive cancer phenotypes
@en
P2093
Vivi Ann Flørenes
Zhenhe Suo
Zhihui Wang
P2860
P2888
P356
10.1186/1471-2407-10-233
P407
P577
2010-05-25T00:00:00Z
P5875
P6179
1042078995